BeyondSpring (BYSI) Non-Current Debt (2019 - 2021)
BeyondSpring's (BYSI) quarterly Non-Current Debt came in at $635000.0 in Q1 2021, down 55.06% year-over-year from $1.4 million in Q1 2020, and down 70.7% quarter-over-quarter from $2.2 million in Q4 2020.
Analysis
BeyondSpring (BYSI) Non-Current Debt (2019 - 2021) Analysis & Trends
BeyondSpring has disclosed Non-Current Debt across 3 years of filings, most recently posting $635000.0 for Q1 2021.
- In Q1 2021, Non-Current Debt fell 55.06% year-over-year to $635000.0; the TTM figure through Mar 2021 stood at $635000.0 (down 55.06% YoY), while the FY2020 annual figure was $2.2 million, up 50.91% from the prior year.
- Non-Current Debt came in at $635000.0 for Q1 2021 at BeyondSpring, down from $2.2 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $3.0 million in Q1 2019 to a low of $635000.0 in Q1 2021.
- Average Non-Current Debt over 3 years is $1.9 million, with a median of $2.0 million recorded in 2020.
- Year-over-year, Non-Current Debt jumped 50.91% in 2020 and tumbled 55.06% in 2021.
- Over 3 years, Non-Current Debt stood at $1.4 million in 2019, then surged by 50.91% to $2.2 million in 2020, then slumped by 70.7% to $635000.0 in 2021.
- Per Business Quant data, the three most recent Non-Current Debt figures were $635000.0 in Q1 2021, $2.2 million in Q4 2020, and $2.1 million in Q3 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 37.34 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 62.48 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 51.08 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | - |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | 60.50 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 17.02 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | - |
| 10 | BeyondSpring | 31.51 Mn | 31.51 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2021 | 635,000.00 |
| Dec 31, 2020 | 2.17 Mn |
| Sep 30, 2020 | 2.11 Mn |
| Jun 30, 2020 | 2.05 Mn |
| Mar 31, 2020 | 1.41 Mn |
| Dec 31, 2019 | 1.44 Mn |
| Sep 30, 2019 | 1.40 Mn |
| Jun 30, 2019 | 2.91 Mn |
| Mar 31, 2019 | 2.98 Mn |